85 - Risk Factors and Outcomes of Resistant CMV Infections in Hematopoietic Cell Transplant Recipients: a 7-Year Review

Co-Author(s)

• MD

  Marilyne Daher, M.D.

  Infectious Diseases, Infection Control, and Employee Health
  Houston, Texas, United States

Co-Author(s)

• 

  Jennifer Makhoul, MD (she/her/hers)

  Fellow / Dr.
  University of Texas Health Science Center at Houston/MD Anderson Cancer Center
  Houston, TX, United States
• VL

  Vielka Lopez, n/a

  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• 

  Tali Shafat, MD

  Postdoctoral research fellow
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• AS

  Amy Spallone, M.D.

  University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• TS

  Terri Lynn Shigle, PharmD, BCOP

  Clinical Pharmacy Specialist
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States
• JS

  Joseph Sassine, MD

  Assistant Professor of Medicine
  University of Oklahoma Health Sciences Center
  Oklahoma City, OK, United States
• AF

  Anthony Febres, MD

  The University of Texas at San Antonio
  Houston, Texas, United States
• OM

  Oscar Morado-Aramburo, MD

  Hospital Beneficiencia Española
  San Luis Potosi, San Luis Potosi, Mexico
• 

  Ella Ariza Heredia, MD

  Associate Professor
  The University of Texas MD Anderson Cancer Center
  Houston, Texas, United States

Presenting Author(s)

• 

  Fareed Khawaja, MBBS

  Associate Professor
  The University of Texas MD Anderson Cancer Center
  Houston, TX, United States

  Slides

Co-Author(s)

• 

  Roy F. Chemaly, MD/MPH (he/him/his)

  Gerald P Bodey, Sr Distinguished Professor of Infectious Diseases
  University of Texas MD Anderson Cancer Center
  Houston, TX, United States